help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCusker, R. H.
Right arrow Articles by Clemmons, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCusker, R. H.
Right arrow Articles by Clemmons, D. R.

Endocrinology, Vol 134, 2095-2102, Copyright © 1994 by Endocrine Society


ARTICLES

Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro

RH McCusker and DR Clemmons
Department of Animal Sciences, University of Illinois, Urbana 61801.

The insulin-like growth factors (IGF-I and IGF-II) stimulate muscle cell proliferation and/or differentiation (depending upon the culture conditions). They also increase IGF-binding protein (IGFBP) levels in muscle cell conditioned media and in some instances there is a direct correlation between the apparent rate of IGFBP secretion and muscle cell proliferation. We have investigated the effect of other cytokines on muscle cell IGFBP conditioned media levels using rat skeletal (L6), mouse myocytes (BC3H-I) and porcine vascular smooth (pVSM) muscle cells in vitro to determine if this relationship is maintained. IGFBP levels in conditioned media (CM) were measured by an [125I]IGF-I binding capacity assay and by western blot analysis. Immunoblots indicated that BC3H-1 and L6 cells secrete IGFBP-5 (31-32,000 M(r)), L6 cells secrete IGFBP-4, and pVSM cells secrete IGFBP-2 (34,000 M(r)). Both L6 and BC3H- 1 cells responded to transforming growth factor beta 1 (TGF-beta 1), in a dose-dependent manner, with suppressed conditioned media levels of IGFBP-4 and IGFBP-5 but TGF-beta 1 did not affect IGFBP-2 levels in pVSM cell media. TGF-beta 1 (5 ng/ml) suppressed IGFBP levels (CM [125I]IGF-I binding capacity) in L6 and BC3H-1 cell media by 48% and 61%, respectively. IGFBP-5 levels, in BC3H-1 cell media, were decreased by treatment with either basic fibroblast growth factor (bFGF) or epidermal growth factor (EGF). Neither treatment affected IGFBP-2 levels. In contrast in L6 myoblasts, bFGF increased media levels of IGFBP-4 and IGFBP-5; L6 cells were not responsive to EGF. Insulin increased IGFBP-4 and IGFBP-5 levels in L6 and BC3H-1 cell media. This stimulatory effect was markedly suppressed by either TGF-beta 1 (L6 and BC3H-1 cells) or bFGF (BC3H-1 cells). L6 and BC3H-1 cell CM IGFBP levels were also suppressed 34% and 84% by 5 U/ml thrombin, respectively. The inhibitory activity of thrombin was specific, i.e. reversible by hirudin and was not due to direct IGFBP proteolysis. Since suramin and staurosporine increased media levels of the IGFBP, this suggests that constitutive secretion of TGF-beta 1, bFGF, or EGF might provide a tonic suppressive mechanism for controlling IGFBP secretion. Thus, our results support the conclusion that the secretion of IGFBP-4 and IGFBP-5, but not IGFBP-2, by muscle cells was suppressed by several cytokines. Depressed IGFBP secretion may play a key role in determining muscle cell responsiveness to either the mitogenic or differentiation stimulating activity of the IGFs.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults
Endocr. Rev., May 1, 2006; 27(3): 287 - 317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Pilewski, L. Liu, A. C. Henry, A. V. Knauer, and C. A. Feghali-Bostwick
Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition
Am. J. Pathol., February 1, 2005; 166(2): 399 - 407.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington
Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro
Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1475 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington
Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro
Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1475 - 1484.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
G. R. Adams
Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation
J Appl Physiol, September 1, 2002; 93(3): 1159 - 1167.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Haddad and G. R. Adams
Exercise Effects on Muscle Insulin Signaling and Action: Selected Contribution: Acute cellular and molecular responses to resistance exercise
J Appl Physiol, July 1, 2002; 93(1): 394 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Rousse, F. Lallemand, D. Montarras, C. Pinset, A. Mazars, C. Prunier, A. Atfi, and C. Dubois
Transforming Growth Factor-beta Inhibition of Insulin-like Growth Factor-binding Protein-5 Synthesis in Skeletal Muscle Cells Involves a c-Jun N-terminal Kinase-dependent Pathway
J. Biol. Chem., December 7, 2001; 276(50): 46961 - 46967.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. P. Ciaraldi, L. Carter, G. Seipke, S. Mudaliar, and R. R. Henry
Effects of the Long-Acting Insulin Analog Insulin Glargine on Cultured Human Skeletal Muscle Cells: Comparisons to Insulin and IGF-I
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5838 - 5847.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Anwar, A. A. Zahid, L. Phillips, and P. Delafontaine
Insulin-Like Growth Factor Binding Protein-4 Expression Is Decreased by Angiotensin II and Thrombin in Rat Aortic Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen
Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Mauras, V. Hayes, S. Welch, A. Rini, K. Helgeson, M. Dokler, J. D. Veldhuis, and R. J. Urban
Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1886 - 1892.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. Canalis and B. Gabbitas
Skeletal Growth Factors Regulate the Synthesis of Insulin-like Growth Factor Binding Protein-5 in Bone Cell Cultures
J. Biol. Chem., May 5, 1995; 270(18): 10771 - 10776.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society